Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Enodia Therapeutics | 2026 | Seed | $24.2M | Paris |
| Nano Corp | 2026 | Non Equity Assistance | Undisclosed | Paris |
| Sim&Cure | 2025 | Series A | $11.6M | Grabels |
| NcodiN | 2025 | Seed | $18.5M | Palaiseau |
| GetVocal AI | 2025 | Series A | $26.0M | Paris |
| mimic | 2025 | Seed | $16.0M | Zürich |
| Primaa | 2025 | Series Unknown | $8.1M | Paris |
| Djust | 2025 | Series A | $8.2M | Paris |
| Vibe | 2025 | Series B | $50.0M | Chicago |
| Seyna | 2025 | Series Unknown | $11.8M | Neuilly-sur-seine |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 51 | Enodia Therapeutics | Seed | $24.2M | Paris, France |
| 52 | Nano Corp | Non Equity Assistance | Undisclosed | Paris, France |
| 53 | Sim&Cure | Series A | $11.6M | Grabels, France |
| 54 | NcodiN | Seed | $18.5M | Palaiseau, France |
| 55 | GetVocal AI | Series A | $26.0M | Paris, France |
| 56 | mimic | Seed | $16.0M | Zürich, Switzerland |
| 57 | Primaa | Series Unknown | $8.1M | Paris, France |
| 58 | Djust | Series A | $8.2M | Paris, France |
| 59 | Vibe | Series B | $50.0M | Chicago, United States |
| 60 | Seyna | Series Unknown | $11.8M | Neuilly-sur-seine, France |
Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases.
Nano Corp secures and monitors hybrid networks.
Sim&Cure develops the medical software Sim&Size® to optimize the choice of endovascular devices for the treatment of cerebral aneurysm.
NcodiN develops nanophotonic chips for data transport for processors that improves speed, energy efficiency and heating of the circuit
GetVocal AI is help companies automate customer service processes with the most advanced Conversational AI phone agent.
Mimic specializes in AI and robotic solutions that focuses on automating tedious tasks in various industries.
Primaa provides AI-based software for pathologists to detect cancer biomarkers and analyze medical images efficiently.
DJUST is a digital B2B e-commerce platform.
Vibe is a streaming TV advertising company for small and medium-sized businesses.
Seyna is an insurance platform that builds a modern insurance ecosystem for brokers.
Proxima Fusion develops stellarator-based fusion reactors to deliver clean, continuous energy through advanced simulation and engineering.
Rapydo provides a platform for real-time monitoring, query control, and automated optimization of MySQL and PostgreSQL databases.
Quantum technology spin-out from the University of Oxford
Moments Lab develops AI technology for analyzing and organizing video content for media, sports, and brand organizations.
SeqOne is a next generation genomic analysis for next generation healthcare.
Azalea Vision is a medical manufacturer designing contact lenses with an active light management system for people with ocular disorders.
Aqemia accelerates drug discovery using quantum physics and AI, generating novel drug candidates without experimental data.
Hema.to provides fully automated, AI-powered blood cancer detection suggestions based on flow cytometry data.
Zymvol accelerates the discovery & development of new industrial enzymes through computer simulations.
Alice&Bob build Universal, Error-free, Quantum Computers to help industries and researchers solve the hardest problems.
Gleamer develops medical grade AI for Radiology
inHEART provides cloud-based medical image analysis solutions for cardiac interventions on patients with arrhythmias.
Dunia Innovations is a Breakthrough materials for tomorrow's net zero planet.
AI claims platform for health & life insurance
SURGAR provides a plug-and-play augmented reality software suite for computer-aided laparoscopic surgery.
Elaia has invested in 123 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Elaia's top investment sectors include Artificial Intelligence (AI), Software, Health Care, Biotechnology, Medical Device. The firm invests across 48 different industry categories.
Among tracked funding rounds, Alice & Bob received $104.3M in a Series B round. Elaia's total known invested capital is $1.1B.
Elaia's average investment size is $14.4M across its portfolio of 123 companies.
Recent Elaia portfolio additions include Enodia Therapeutics, Nano Corp, Sim&Cure, NcodiN, GetVocal AI. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors